Ketoconazole - indications restricted

Several of the indications for Nizoral (ketoconazole) 200mg tablets have been removed due to a risk of serious hepatotoxicity.

Following a systematic review of available data, therapeutic use is now restricted to patients resistant to, or intolerant of, other effective antifungal therapies.

The following indications have been removed from the Summary of Product Characteristics (SPC):
- chronic, recurrent vaginal candidosis
- systemic fungal infections
- prophylaxis of mycotic infections in patients with reduced immune responses
- systemic candidosis
- culturally determined dermatophyte infections of fingernails
- oesophageal candidosis
- treatment of paracoccidioidomycosis, histoplasmosis, coccidioidmycosis and blastomycosis.

The updated SPC also includes new warnings about the duration of treatment (thought to be the main risk factor for serious hepatotoxicity), monitoring requirements for hepatic function (before and during treatment), the addition of drugs that are contraindicated for use with ketoconazole and new post-marketing adverse effects

Further information: MHRA

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases